Insights Into Atara Biotherapeutics's Upcoming Earnings
Insights Into Atara Biotherapeutics's Upcoming Earnings
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).Atara Biotherapeutics (NASDAQ:ATRA) is gearing up to announce its quarterly earnings on Tuesday, 2024-11-12. Here's a quick overview of what investors should know before the release.
atara biotherapeutics（纳斯达克股票代码：ATRA）将于2024年11月12日星期二宣布季度财报。在公布之前，这里是投资者应该了解的快速概述。
Analysts are estimating that Atara Biotherapeutics will report an earnings per share (EPS) of $-1.93.
分析师预计Atara Biotherapeutics的每股收益（EPS）为-1.93美元。
Atara Biotherapeutics bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
Atara Biotherapeutics的支持者们希望听到公司不仅打破这一预期，还能提供积极的指导，或者对下个季度的增长进行预测。
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
新投资者应该注意，有时不是盈利与否影响股票价格最大，而是其提供的指导或预测。
Performance in Previous Earnings
Performance in Previous Earnings
The company's EPS missed by $1.54 in the last quarter, leading to a 3.22% increase in the share price on the following day.
公司上季度每股收益低于1.54美元，导致次日股价上涨了3.22%。
Here's a look at Atara Biotherapeutics's past performance and the resulting price change:
这是Atara Biotherapeutics过去表现以及导致的股价变化。
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -1.56 | -6.50 | -12 | -16.5 |
| EPS Actual | -3.10 | -5.75 | -14 | -16.5 |
| Price Change % | 3.0% | -3.0% | -1.0% | -6.0% |
| 季度 | 2024年第二季度 | Q1 2024 | 2023年第四季度 | 2023年第三季度 |
|---|---|---|---|---|
| 每股收益预估值 | -1.56 | -6.50 | -12 | -16.5 |
| 每股收益实际值 | -3.10 | -5.75 | -14 | -16.5 |
| 价格变更% | 3.0% | -3.0% | -1.0% | -6.0% |
Tracking Atara Biotherapeutics's Stock Performance
追踪atara biotherapeutics的股票表现
Shares of Atara Biotherapeutics were trading at $11.31 as of November 08. Over the last 52-week period, shares are up 41.23%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.
atara biotherapeutics的股票价格截至11月08日为11.31美元。在过去的52周里，股价上涨了41.23%。鉴于这些回报通常是积极的，长期股东在参与财报发布之前应该感到满意。
To track all earnings releases for Atara Biotherapeutics visit their earnings calendar on our site.
要追踪atara biotherapeutics的所有财报发布，请访问我们站点上的财报日历。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文是由Benzinga的自动内容引擎生成，并由编辑审核。
